– USA, NC – EnPro Industries, Inc. (NYSE: NPO), an industrial technology company, today announced the election of Judith Reinsdorf to its Board of Directors.
“We welcome Judy to the Enpro Board. Through her 32-year career, she has demonstrated important leadership and strategic acumen, as well as governance expertise, that will benefit our company as we proceed in our optimization efforts and execute on our sharpened growth strategy,” said Board Chairman, David Hauser.
About Judy Reinsdorf
Judy Reinsdorf was previously EVP and General Counsel at Johnson Controls (NYSE: JCI) until her retirement in 2017. She held the same role at Tyco International from 2007 until 2016. Currently, Reinsdorf is on the Compensation Committee at Cornerstone Building Brands (NYSE: CNR), serves on the advisory board of Teach for America – New Jersey and the NACD New Jersey Chapter. Judy chaired the Governance Committee at both Alexion Pharmaceuticals, until the July 2021 acquisition by AstraZeneca, and at Dun & Bradstreet from 2013 until 2019, when the company was taken private.
Ms. Reinsdorf came to Tyco International under CEO Ed Breen’s tenure and was a key member of the transformation team at Tyco that successfully reshaped the company’s portfolio and growth strategy. During her tenure, Tyco completed several strategic acquisitions and non-core business divestitures. She began her career in 1989 as an Associate at Crowell & Moring and held various Legal Counsel positions at Monsanto, Pharmacia, and C.R. Bard.
About Enpro
Enpro is an industrial technology company focused on niche applications across many end-markets including semiconductor, general industrial, aerospace, food and pharma, and life sciences.
For more information: https://www.enproindustries.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.